Related Experiment Video
Updated: Jul 28, 2026

Differentiation of Human Pluripotent Stem Cells Into Pancreatic Beta-Cell Precursors in a 2D Culture System
Published on: December 16, 2021
Reconstructing human pancreatic gene networks enhances stem cell-derived β cell induction.
Xin-Xin Yu1, Xin Wang2, Liu Yang1
1State Key Laboratory of Female Fertility Promotion, Department of Medical Genetics, School of Basic Medical Sciences, Peking University, Beijing 100191, China; Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing 100871, China.
Researchers developed a new protocol to generate functional beta cells from stem cells. This method improves stem cell-derived beta cell (SC-β cell) induction efficiency by mimicking human pancreatic development.
Area of Science:
- Developmental Biology
- Stem Cell Biology
- Regenerative Medicine
Background:
- Generating functional beta cells from stem cells is crucial for regenerative medicine but challenging due to incomplete in vitro recapitulation of human pancreatic development.
- Existing stem cell differentiation protocols often fail to replicate the complex gene co-expression networks (GCNs) observed during human pancreatic development.
Purpose of the Study:
- To map gene co-expression networks (GCNs) underlying human and mouse pancreatic lineage progression.
- To benchmark current differentiation protocols against in vivo data and identify limitations.
- To develop an improved protocol that reconstructs human pancreatic GCN dynamics for efficient stem cell-derived beta cell (SC-β cell) generation.
Main Methods:
- Integrated single-cell RNA sequencing (RNA-seq) datasets from human embryos (Carnegie stages 10-15) and mice to map GCNs.
- Benchmarked three common stem cell differentiation protocols against in vivo GCN data.
- Developed and tested a novel protocol designed to reconstruct human pancreatic GCN dynamics.
Main Results:
- Identified significant species-specific differences in GCN robustness and progenitor development.
- Demonstrated that current protocols do not reproduce human-like GCNs, limiting SC-β cell induction.
- The new protocol shortened induction to 19 days and achieved up to ~70% β cell content.
- Transplanted SC-islets alleviated diabetic symptoms in mice and maintained mature β cell function.
Conclusions:
- The developed protocol effectively reconstructs human pancreatic GCN dynamics, overcoming limitations of previous methods.
- This advancement significantly improves the efficiency and maturity of stem cell-derived beta cells.
- The findings bridge the gap between in vivo developmental mechanisms and in vitro differentiation, paving the way for improved stem cell-based therapies for diabetes.
Related Concept Videos
Tissue Renewal without Stem Cells
However, failure of such a system...
Somatic to iPS Cell Reprogramming

